[:el]
Elli Papaemmanuil is an assistant professor at the Memorial Sloan Kettering Cancer Center. The molecular geneticist performs systematic interrogations of well annotated clinical trial cohorts in leukemia and cancer to explore how the compound genetic and clonal architecture in patients leukemias and tumors dictate clinical phenotype, disease progression and clinical outcomes.
As head of the research group, she discovered the gene that causes childhood leukemia. The conclusion of the research on myelodysplasia is that new, introspective jottings would facilitate the genetic screening mutation.
She performed tests on 1,450 patients with acute myeloid leukemia and discovered that these patients with apparently the same disease are separated in at least 11 large groups. Those groups had similarities between them like older age patients or some groups responded similar to chemotherapy while other groups did not. With a more thorough analysis, it seems that the 70% of the differences in the development of leukemia is based upon the genetic mutations. The research was published in the “New England Journal of Medicine” while it has been presented in the 21st Congress of the European Hematology Association in Copenhagen in June 2016 by herself.
Elli Papaemmanuil was born in Athens. In 2004, she received her Bachelor from the University of Glasgow. Pursuing a research career on cancer, she was granted a doctorate scholarship in London Cancer Research Institute, where she conducted a series of research on genetic diathesis for large intestine cancer and childhood leukemia and published on the identification of the first gene locus relating to increased risk of developing childhood leukemia.
Later on, from 2010 till 2014, Elli Papaemmanuil worked at the Wellcome Trust Sanger Institute as a senior post doctoral research fellow. From 2014 until present, the Greek scientist works as a junior team leader at the University of Cambridge. From March 2015, she is an assistant professor at the Memorial Sloan Kettering Cancer Center (MSKCC).
She is the main coordinator of centers on more than 30 countries with the task to collect and examine more than 17.000 specimens that cover almost all the forms of leukemia.
[The geneticist biologist Elli Papaemmanouil lies behind the discovery of the relationship of the gene with blood cancer. As head of the research group, she discovered the gene that causes childhood leukemia. The conclusion of the research on myelodysplasia is that new, introspective jottings would facilitate the genetic screening mutation.
Born in Athens and having spent her life between London and Naples, Dr. Papaemmanouil decided to follow her academic career in the field of molecular genetics and resided to the UK to continue her studies in the University of Glasgow.
Pursuing a research career on cancer, she was granted a doctorate scholarship in London Cancer Research Institute, where she conducted a series of research on genetic diathesis for large intestine cancer and childhood leukemia and published on the identification of the first gene locus relating to increased risk of developing childhood leukemia.
Later on, Dr. Elli Papaemmanouil worked in the Wellcome Trust Sanger Genome Campus of Cambridge University, one of the leading genome research institutes in the world.
[:]
